Septerna, Inc. (NASDAQ:SEPN) Given Consensus Rating of “Moderate Buy” by Brokerages

Septerna, Inc. (NASDAQ:SEPN) has been given an average rating of “Moderate Buy” by the eleven brokerages that are covering the stock, MarketBeat Ratings reports. One research analyst has rated the stock with a sell rating, one has assigned a hold rating, eight have given a buy rating and one has assigned a strong buy rating to the company. The average 1-year price objective among brokerages that have covered the stock in the last year is $45.8889.

A number of equities research analysts have recently issued reports on the stock. Weiss Ratings restated a “sell (d-)” rating on shares of Septerna in a report on Friday, July 17th. Truist Financial upped their target price on Septerna from $35.00 to $43.00 and gave the stock a “buy” rating in a research report on Wednesday, July 1st. HC Wainwright restated a “buy” rating and set a $40.00 price target on shares of Septerna in a report on Wednesday, July 1st. Guggenheim cut their price objective on Septerna from $52.00 to $45.00 and set a “buy” rating on the stock in a research note on Wednesday, July 1st. Finally, Raymond James Financial lifted their price target on shares of Septerna from $47.00 to $53.00 and gave the company a “strong-buy” rating in a research report on Monday, June 8th.

Insiders Place Their Bets

In other Septerna news, insider Samira Shaikhly sold 11,798 shares of the business’s stock in a transaction on Tuesday, May 26th. The shares were sold at an average price of $30.06, for a total transaction of $354,647.88. Following the completion of the transaction, the insider owned 793 shares of the company’s stock, valued at $23,837.58. The trade was a 93.70% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, SVP Daniel D. Long sold 15,000 shares of the company’s stock in a transaction dated Monday, June 22nd. The shares were sold at an average price of $35.51, for a total transaction of $532,650.00. Following the sale, the senior vice president owned 96,412 shares of the company’s stock, valued at $3,423,590.12. This trade represents a 13.46% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 44,494 shares of company stock worth $1,469,391 over the last quarter. 5.80% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Septerna

Institutional investors have recently made changes to their positions in the business. Goldman Sachs Group Inc. lifted its position in shares of Septerna by 86.6% during the 4th quarter. Goldman Sachs Group Inc. now owns 2,715,129 shares of the company’s stock worth $75,698,000 after purchasing an additional 1,260,409 shares during the last quarter. Vanguard Group Inc. grew its holdings in Septerna by 7.4% in the 3rd quarter. Vanguard Group Inc. now owns 1,518,757 shares of the company’s stock valued at $28,568,000 after buying an additional 104,394 shares during the last quarter. ADAR1 Capital Management LLC grew its holdings in Septerna by 38.9% in the 3rd quarter. ADAR1 Capital Management LLC now owns 1,176,491 shares of the company’s stock valued at $22,130,000 after buying an additional 329,264 shares during the last quarter. Janus Henderson Group PLC bought a new position in Septerna in the 1st quarter worth approximately $21,334,000. Finally, First Light Asset Management LLC increased its position in Septerna by 18.0% in the 1st quarter. First Light Asset Management LLC now owns 732,860 shares of the company’s stock worth $17,611,000 after buying an additional 112,049 shares during the period.

Septerna Trading Up 1.2%

Shares of NASDAQ SEPN opened at $33.49 on Tuesday. Septerna has a twelve month low of $10.62 and a twelve month high of $38.04. The company has a market capitalization of $1.51 billion, a price-to-earnings ratio of -41.35 and a beta of 2.29. The firm has a 50-day moving average of $33.06 and a two-hundred day moving average of $28.36.

Septerna (NASDAQ:SEPN) last posted its quarterly earnings results on Monday, May 11th. The company reported ($0.19) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.42) by $0.23. The firm had revenue of $26.52 million for the quarter, compared to analyst estimates of $16.98 million. Septerna had a negative net margin of 49.88% and a negative return on equity of 12.72%. As a group, research analysts predict that Septerna will post -1.59 earnings per share for the current year.

Septerna Company Profile

We are a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by our proprietary Native Complex Platform™. Our industrial-scale platform aims to unlock the full potential of GPCR therapies and has led to the discovery and development of our deep pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic diseases. GPCRs are the largest and most diverse family of cell membrane receptors and regulate physiological processes in nearly every organ system of the human body.